Austar Lifesciences Limited
AULSF
$0.07
$0.0651,300.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.99M | 23.92M | 19.26M | 19.39M | 24.51M |
| Total Receivables | 139.51M | 145.17M | 142.17M | 143.08M | 143.96M |
| Inventory | 32.67M | 33.99M | 34.59M | 34.81M | 34.29M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 17.43M | 18.14M | 19.13M | 19.25M | 19.19M |
| Total Current Assets | 212.60M | 221.22M | 215.15M | 216.54M | 221.95M |
|
|
|||||
| Total Current Assets | 212.60M | 221.22M | 215.15M | 216.54M | 221.95M |
| Net Property, Plant & Equipment | 56.74M | 59.04M | 60.26M | 60.65M | 62.59M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.80M | 6.03M | 5.52M | 5.55M | 5.99M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.08M | 2.16M | 2.21M | 2.22M | 2.36M |
| Total Assets | 285.46M | 297.05M | 294.05M | 295.94M | 304.47M |
|
|
|||||
| Total Accounts Payable | 52.35M | 54.47M | 51.72M | 52.05M | 57.25M |
| Total Accrued Expenses | 15.24M | 15.86M | 14.51M | 14.60M | 16.11M |
| Short-term Debt | 31.48M | 32.75M | 31.06M | 31.26M | 36.01M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.87M | 16.52M | 14.22M | 14.31M | 10.99M |
| Total Finance Division Other Current Liabilities | 47.91M | 49.85M | 51.93M | 52.26M | 45.74M |
| Total Other Current Liabilities | 47.91M | 49.85M | 51.93M | 52.26M | 45.74M |
| Total Current Liabilities | 162.85M | 169.46M | 163.43M | 164.48M | 166.08M |
|
|
|||||
| Total Current Liabilities | 162.85M | 169.46M | 163.43M | 164.48M | 166.08M |
| Long-Term Debt | 3.44M | 3.58M | 10.39M | 10.46M | 15.63M |
| Short-term Debt | 31.48M | 32.75M | 31.06M | 31.26M | 36.01M |
| Capital Leases | 4.27M | 4.45M | 6.72M | 6.76M | 7.35M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.18M | 6.44M | 6.08M | 6.12M | 6.04M |
| Total Liabilities | 176.76M | 183.93M | 186.63M | 187.82M | 195.11M |
|
|
|||||
| Common Stock & APIC | 47.08M | 48.99M | 47.29M | 47.59M | 48.46M |
| Retained Earnings | 54.99M | 57.22M | 53.83M | 54.18M | 54.34M |
| Treasury Stock & Other | 6.36M | 6.62M | 6.18M | 6.22M | 6.22M |
| Total Common Equity | 108.43M | 112.82M | 107.30M | 107.99M | 109.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 108.43M | 112.82M | 107.30M | 107.99M | 109.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 282.10K | 293.50K | 125.10K | 125.90K | 346.90K |
| Total Equity | 108.71M | 113.12M | 107.42M | 108.11M | 109.36M |
|
|
|||||